SECTOR : Biotech
ENTRY DATE : 2020
BUSINESS : Venture Capital
WEB : https://algotx.com/

AlgoTherapeutix

Development of novel solutions to relieve patients with difficult-to-treat complex pain.

Founded in 2018, AlgoTherapeutix is a French biotech company developing topical products to treat chemotherapy-induced peripheral neuropathy.

PRESS RELEASE :

24/11/2021 • AlgoTherapeutix raises €12M to take ATX01 into clinical development in chemotherapy-induced peripheral neuropathy
Lire